Nivolumab 3mg/kg every 2 weeks

2 trials

Sponsors

National Cancer Center Hospital, Fujita Health University School

Conditions

advanced sarcomatoid carcinoma of the lungnon-small cell lung cancer

Phase 2

A single arm confirmatory study of nivolumab in patients with previously treated advanced sarcomatoid carcinoma of the lung

Active, not recruitingJPRN-UMIN000023433

National Cancer Center Hospitaladvanced sarcomatoid carcinoma of the lung

Start: 2017-03-27Target: 42Updated: 2026-06-29

Phase II trial of early secondary treatment with nibolumab for non-small cell lung cancer

Active, not recruitingJPRN-UMIN000030457

Fujita Health University Schoolnon-small cell lung cancer

Start: 2018-01-01Target: 30Updated: 2026-06-29